OREANDA-NEWS. On behalf of Sberbank, the Zapadno-Uralsky Bank has provided a number of credit products to Pharmaimpex worth a total of RUB 650 mln. Funds will be used to carry out investment projects and replenish the company's working capital for the purchase of medicines.

"Pharmaintex is adhering to a well-thought-out economic strategy that is positively affecting the stability of the business," commented Svetlana Sagaidak, Senior Vice-President of Sberbank. "Cooperation with Sberbank will, among other things, help the company to widen its retail chain."

Pharmaimpex Group operates in 17 Russian regions. The Group's management company is located in Izhevsk.